| Mepha Pharma AG - Rivaroxaban-Mepha 15 mg, Hartkapseln | | 69305 | | 02 | | Rivaroxaban-Mepha 15 mg | | Hartkapseln | | B01AF01 | | Rivaroxaban | | 31.01.2025 | | |
| | Composition | | rivaroxabanum 15.0 mg, cellulosum microcristallinum, lactosum monohydricum 19.50 mg, tricalcii dicitras tetrahydricus, povidonum K 25, carmellosum natricum conexum, natrii laurilsulfas, silica colloidalis anhydrica, magnesii stearas, Kapselhülle: E 172 (flavum), E 171, carrageenanum, kalii chloridum, aqua purificata, hypromellosum, pro capsula corresp. natrium 0.38 mg et kalium 0.14 mg. | | Packungsbestandteile | | Capsules | | | | | | Active Agent | Dose |
|---|
| Rivaroxabanum | 15 mg |
| | | | Inactive agents | Dose | additional_information |
|---|
| (Flavum) | | | | Aqua Purificata | | | | Carmellosum Natricum Conexum | | | | Carrageenanum | | | | Cellulosum Microcristallinum | | | | E 171 | | color. | | E 172 | | Kapselhülle | | Hypromellosum | | | | Potassium Chloride | | | | Lactose Monohydrate | 19.5 mg | | | Magnesii Stearas | | | | Natrii Laurilsulfas | | | | Povidonum K | 25 | | | Silica Colloidalis Anhydrica | | | | Tricalcii Dicitras Tetrahydricus | | |
|
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 004 | 10 | | | B | | Yes | | 005 | 14 | | | B | | Yes | | 006 | 28 | | | B | | Yes | | 007 | 42 | | | B | | Yes | | 008 | 98 | | | B | | Yes |
|
|
